2022 NAICS national industry in sector 31-33 Manufacturing

325412 Pharmaceutical Preparation Manufacturing

NAICS 325412 is the US industry code for pharmaceutical preparation manufacturing. This U.S.

Code
325412 (2022 NAICS)
Title
Pharmaceutical Preparation Manufacturing
Part of
Pharmaceutical and Medicine Manufacturing
SBA small business limit
Up to 1,300 employees

Changes coming. The NAICS 2027 revision applies to data from 1 January 2027, and SBA proposed new size standards on 20 August 2026. The values on this page are the ones in force today; we update this page when the official files change.

Official definition

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

Source: US Census Bureau, 2022 NAICS descriptions.

When to use a different code

Census classifies these close-sounding activities somewhere else. Businesses mainly engaged in:

Source: US Census Bureau, 2022 NAICS cross-references.

Activities listed under 325412

The Census index assigns these 74 activities to this code. If your business matches one, this is your code.

Source: US Census Bureau, 2022 NAICS index file.

SBA size standard for 325412

To count as a small business for SBA loans and federal contracts under NAICS 325412, your business (including affiliates) must not exceed 1,300 employees. Check your business.

Source: SBA table of size standards, effective March 17, 2023.

Similar codes to compare

Data last changed November 14, 2026. How this page is built.